Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and isotretinoin

fluorodeoxyglucose f18 has been researched along with isotretinoin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bender, H; Biersack, HJ; Fimmers, R; Grünwald, F; Menzel, C; Otte, R; Palmedo, H; Risse, J1
Boerner, AR; Fricke, H; Hofmann, M; Knapp, WH; Langen, KJ; Otto, D; Petrich, T; Weckesser, E; Weckesser, M1
Bredow, J; Franke, WG; Grüning, T; Kropp, J; Tiepolt, C; Zöphel, K1
Ashraf, A; Bremner, JD; Brummer, ME; Cummins, T; Fani, N; Goodman, MM; Nemeroff, CB; Reed, L; Siddiq, S; Vaccarino, V; Votaw, JR1
Arisaka, O; Fukushima, K; Hashimoto, T; Kurosawa, H; Kuwashima, S; Okamoto, K; Sakamoto, S; Sato, Y; Tsuchioka, T1

Other Studies

5 other study(ies) available for fluorodeoxyglucose f18 and isotretinoin

ArticleYear
Redifferentiation therapy-induced radioiodine uptake in thyroid cancer.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998, Volume: 39, Issue:11

    Topics: Adenocarcinoma, Follicular; Aged; Carcinoma, Papillary; Case-Control Studies; Combined Modality Therapy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Isotretinoin; Male; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed

1998
Monitoring isotretinoin therapy in thyroid cancer using 18F-FDG PET.
    European journal of nuclear medicine and molecular imaging, 2002, Volume: 29, Issue:2

    Topics: Adenocarcinoma; Adenocarcinoma, Follicular; Adult; Aged; Antineoplastic Agents; Carcinoma, Papillary; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Isotretinoin; Male; Middle Aged; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed

2002
Retinoic acid for redifferentiation of thyroid cancer--does it hold its promise?
    European journal of endocrinology, 2003, Volume: 148, Issue:4

    Topics: Adenocarcinoma, Follicular; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Isotretinoin; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Retrospective Studies; Thyroid Neoplasms; Tomography, Emission-Computed; Treatment Outcome

2003
Functional brain imaging alterations in acne patients treated with isotretinoin.
    The American journal of psychiatry, 2005, Volume: 162, Issue:5

    Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Brain; Depressive Disorder; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Isotretinoin; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Psychiatric Status Rating Scales; Severity of Illness Index; Tissue Distribution

2005
Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography for Follow-Up of 13-cis-Retinoic Acid Treatment for Residual Neuroblastoma After Myeloablative Chemotherapy.
    Medicine, 2015, Volume: 94, Issue:31

    Topics: Abdominal Neoplasms; Child; Combined Modality Therapy; Dermatologic Agents; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Isotretinoin; Male; Neoplasm, Residual; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome

2015